Comparison of long-term immunogenicity (23 y) of 10 μg and 20 μg doses of hepatitis B vaccine in healthy children
Volume 8, Issue 8
Purchase or Subscribe
Pages 1071 - 1076http://dx.doi.org/10.4161/hv.20656
: Anamnestic response, HBV, Hepatitis B, PDV, Vaccine, anti-HBs, clinical trial, immune response, long-term, plasma-derived vaccine, vaccine intervention study
Authors: Qian Wu, Gui-hua Zhuang, Xue-liang Wang, Tie-jun Hou, Dimpy P. Shah, Xiao-li Wei, Li-rong Wang and Min Zhang View affiliations
To compare the long-term immunogenicity and seroprotection rates in healthy children following 23 years of vaccination with 10 μg or 20 μg doses of plasma-derived hepatitis B vaccine, we revisited all participants from our previous randomized controlled trial. At year 23, 81 participants were tested for HBV serological markers and HBV-DNA, and a booster dose was given to those with anti-HBs titer < 10 mIU/mL. After eliminating the interference of a Year 11 booster dose and vaccines received outside of the trial, around 50% of participants still maintained anti-HBs titers ≥ 10 mIU/mL in both 10 μg and 20 μg groups (p > 0.05). The peak immune response of vaccination (anti-HBs antibody levels at 12 mo after 1st vaccine dose) and Year 11 anti-HBs levels were significantly associated with Year 23 seroprotection rates. Most of the participants in both groups, regardless of their prior immune status, developed a rapid and robust anamnestic antibody response after the booster dose at year 23. No case of clinically significant HBV infection was observed during the entire study period of 23 y with only one transient HBsAg seroconversion in 10 μg vaccine group. We concluded that seroprotection provided by 10μg or 20 μg doses of hepatitis B vaccine persists for 23 years in more than half of vaccinated individuals in highly HBV-endemic areas, irrespective of 10 μg or 20 μg vaccine doses. Future studies with larger sample sizes comparing long-term efficacy of various doses of plasma-derived and recombinant HBV vaccines are recommended.
Received: March 14, 2012; Accepted: May 7, 2012; Published Online: August 1, 2012
Full Text - Ahead of Print Available - Log in!